TNFRSF10B and malignant colon neoplasm: A similar study indicating that treatment with 5-FU or doxorubicin could sensitise colon cancer stem cells to Vγ9Vδ2 T-cell cytotoxicity did look for these markers at the mRNA level but found that only TRAILR2 was significantly upregulated31.